Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients ... “When we compare bariatric ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than ...

A study suggests that bariatric surgery may be more cost-effective in the long run compared to weight loss medications like Ozempic and Wegovy for treating obesity.

Objective—Malabsorptive bariatric surgery (biliopancreatic diversion and biliointestinal bypass [BIBP ... and 6 months after BIBP or AGB. Serum cholesterol (mg/dL) 192.2 ± 3.44 199.7 ± ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...

GT Metabolic Solutions Inc. received U.S. FDA clearance for its Magdi bariatric surgery system. The system uses magnets to create side-to-side duodeno-ileal anastomosis without cutting intestinal ...

Despite being younger, Black patients tended to be more likely to die in the hospital following a bypass surgery than White patients. In total, 3.2% of Black patients passed away soon after their ...